Blood cancer

McKallip RJ1, Lombard C, Fisher M, Martin BR, Ryu S, Grant S, Nagarkatti PS, Nagarkatti M. (2002). "Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease." Blood. 100(2):627-34.

https://www.ncbi.nlm.nih.gov/pubmed/12091357

Jia W1, Hegde VL, Singh NP, Sisco D, Grant S, Nagarkatti M, Nagarkatti PS. (2006). "Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria." Mol Cancer Res. 4(8):549-62.

https://www.ncbi.nlm.nih.gov/pubmed/16908594

*Current research does not guarantee that cannabinoids will cure any condition. However, a growing body of ongoing studies does suggest that these cannabinoids could offer treatment potential for a variety of physical and mental conditions.